Who Paid My Doc
Karl Hafner
Family Medicine Fulton, NY Medical Doctor
NPI 1235132655 CMS profile 146194
98 N 2Nd St, Fulton, NY 13069
General payments
$129
Research payments
$522,462
Ownership & investment interest
$0
Research they led as principal investigator
$460,985
Through program year 2025, Karl Hafner of Fulton, NY is reported in the CMS Open Payments database as having received $129 across 4 general payments and $522,462 in research payments paid to them. Separately, studies naming them as principal investigator received $460,985 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 99th percentile of Family Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | Research | $324 | 1 | |
| 2023 | Research | $300 | 1 | |
| 2022 | Research | $10,940 | 2 | |
| 2021 | General | $12 | 1 | |
| 2021 | Research | $510,747 | 2 | |
| 2020 | Research | $150 | 1 | |
| 2019 | General | $118 | 3 |
Beside peers
- Karl Hafner
- Family Medicine median
- Middle half of Family Medicine
- National median
In program year 2025, general payments to Karl Hafner were reported at $0. Among 56,786 Family Medicine profiles paid that year, the median was $155 and the middle half received between $45 and $549.
Show as a table
| Year | Karl Hafner | Family Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $118 | $150 | $41–$543 | $163 |
| 2020 | $0 | $120 | $32–$415 | $114 |
| 2021 | $12 | $137 | $35–$551 | $132 |
| 2022 | $0 | $137 | $37–$512 | $149 |
| 2023 | $0 | $149 | $42–$545 | $160 |
| 2024 | $0 | $156 | $44–$560 | $164 |
| 2025 | $0 | $155 | $45–$549 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
11 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Related records
Family Medicine in New York
Practitioners in the same specialty and state, ranked by reported value.
All Family Medicine
Everyone recorded under this specialty, nationwide.
Doctors in New York
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.